Literature DB >> 6836120

Redefinitions of indications for percutaneous nephrostomy.

E K Lang, E T Price.   

Abstract

An analysis of treatment response in 215 patients treated by percutaneous nephrostomy identified obstruction of the urinary tract, complicated by infection and sometimes gram-negative septicemia, as the single most important indication for this intervention. Percutaneous nephrostomy reduced the mortality from gram-negative septicemia from 40% to 8%. Similarly, the length of hospitalization for patients with severe infection complicating urinary tract obstruction was reduced by half in the group undergoing percutaneous nephrostomy. In 43 patients with longstanding obstruction, percutaneous nephrostomy was used to predict recoverable renal function based on the response of renal plasma flow rate to decompression. In 13 patients, percutaneous nephrostomies were used either for the introduction of solvents to dissolve calculi or to serve as pathways for their extraction. Percutaneous nephrostomies in 21 patients were expanded to serve as points of entry for the placement of stent catheters to treat fistulas or bougie catheters to dilate and subsequently catheterize ureteral strictures. While six serious complications were encountered, five of these might have been prevented by meticulous adherence to proper technique.

Entities:  

Mesh:

Year:  1983        PMID: 6836120     DOI: 10.1148/radiology.147.2.6836120

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  10 in total

Review 1.  Percutaneous nephrostomy and antegrade ureteral stenting: technique-indications-complications.

Authors:  Klaus Armin Hausegger; Horst Rupert Portugaller
Journal:  Eur Radiol       Date:  2006-03-18       Impact factor: 5.315

Review 2.  Interventional procedures in the upper urinary tract.

Authors:  M P Banner; P Ramchandani; H M Pollack
Journal:  Cardiovasc Intervent Radiol       Date:  1991 Sep-Oct       Impact factor: 2.740

3.  Urological complications in gynaecological diseases. Review of 18 cases requiring diversion or reconstruction of the urinary tract.

Authors:  H Shiina; Y Himeno; T Ishibe
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

Review 4.  Emergent Percutaneous Nephrostomy for Pyonephrosis: A Primer for the On-Call Interventional Radiologist.

Authors:  Christopher Florido; Josi L Herren; Mithil B Pandhi; Matthew M Niemeyer
Journal:  Semin Intervent Radiol       Date:  2020-03-04       Impact factor: 1.513

5.  Antibiotic bonded nephrostomy catheters for percutaneous nephrostomies.

Authors:  J L Nosher; A S Ericksen; S Z Trooskin; G S Needell; R A Harvey; R S Greco
Journal:  Cardiovasc Intervent Radiol       Date:  1990 Apr-May       Impact factor: 2.740

6.  Percutaneous nephrostomy versus ureteroscopic management of sepsis associated with ureteral stone impaction: a randomized controlled trial.

Authors:  Chung-Jing Wang; Chi-Sen Hsu; Hung-Wen Chen; Chien-Hsing Chang; Po-Chao Tsai
Journal:  Urolithiasis       Date:  2015-12-11       Impact factor: 3.436

7.  Interventional radiology and the care of the oncology patient.

Authors:  Siobhan B O'Neill; Owen J O'Connor; Max F Ryan; Michael M Maher
Journal:  Radiol Res Pract       Date:  2011-03-29

8.  Emergency percutaneous nephrostomy versus emergency percutaneous nephrolithotomy in patients with sepsis associated with large uretero-pelvic junction stone impaction: a randomized controlled trial.

Authors:  Chi-Sen Hsu; Chung-Jing Wang; Chien-Hsing Chang; Po-Chao Tsai; Hung-Wen Chen; Yi-Chun Su
Journal:  Int Braz J Urol       Date:  2017 May-Jun       Impact factor: 1.541

9.  Complementary Role of Intervention Radiology in Palliative Care in Oncology Setting.

Authors:  Ekta Dhamija; Ashwin Deshmukh; Pankaj Meena; Mukesh Kumar; Sushma Bhatnagar; Sanjay Thulkar
Journal:  Indian J Palliat Care       Date:  2019 Jul-Sep

10.  Acute renal failure due to bilateral uric acid lithiasis in infants.

Authors:  Mete Kaya; M Emin Boleken; Mustafa Soran; Turan Kanmaz; Selçuk Yücesan
Journal:  Urol Res       Date:  2007-03-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.